Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4939722 | 0.94 | LMNA (0.47) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL27731125 | 0.83 | LMNA (0.57) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL28285589 | 0.81 | LMNA (0.55) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL1231766 | 0.80 | LMNA (0.55) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL1284277 | 0.79 | LMNA (0.53) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL10532645 | 0.79 | LMNA (0.53) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL28043565 | 0.79 | LMNA (0.53) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL4534739 | 0.79 | LMNA (0.48) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL10653095 | 0.79 | LMNA (0.48) | LMNAKMT2AKDM4EMAPTMEN1 | |
| SCHEMBL205421 | 0.79 | LMNA (0.48) | LMNAKMT2AKDM4EMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105294700-A | Preparation method for tert-butyl dioxy-3,8-diazabicyclo[3.2.1]octane-8-carboxylic acid | SHANGHAI SYNTHEALL PHARMACEUTICAL CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-103509012-A | Phenanthroindolizidine alkaloid C14-site aminated derivatives, and preparation and anti-plant virus activity thereof | UNIV NANKAI | 2014-01-15 | — | — | CN | claimed |
| CN-102250014-B | Method for preparing chiral 1-benzyloxycarbonyl hexahydropyridazine-3-carboxylic acid and chiral 1, 2-dibenzyloxycarbonyl hexahydropyridazine-3-carboxylic acid | SHANGHAI AOBO BIO PHARMACEUTICAL TECH CO LTD | 2013-11-13 | — | — | CN | claimed |
| CN-1946772-B | Dendritic polymers with enhanced amplification and internal functionality | DENDRITIC NANOTECHNOLOGIES INC | 2013-01-02 | — | — | CN | claimed |
| CN-101443048-B | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES INC | 2013-01-02 | — | — | CN | claimed |
| CN-102250014-A | Method for preparing chiral 1-benzyloxycarbonyl hexahydropyridazine-3-carboxylic acid and chiral 1, 2-dibenzyloxycarbonyl hexahydropyridazine-3-carboxylic acid | SHANGHAI AOBO BIO PHARMACEUTICAL TECH CO LTD | 2011-11-23 | — | — | CN | claimed |
| EP-2385078-A1 | Dendritic polymers with enhanced amplification and interior functionality | Dendritic Nanotechnologies Inc. (US) | 2011-11-09 | — | — | EP | claimed |
| US-20110254461-A1 | Power adaptors | HOLDIP LIMITED (GB) | 2011-10-20 | — | — | US | claimed |
| US-7985424-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES INC. (US) | 2011-07-26 | — | — | US | claimed |
| US-7981444-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2011-07-19 | — | — | US | claimed |
| EP-1737899-A4 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2008-03-05 | — | — | EP | claimed |
| EP-1877103-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | claimed |
| US-20070244296-A1 | Dendritic Polymers with Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-10-18 | — | — | US | claimed |
| CN-1946772-A | Dendritic polymers with enhanced amplification and internal functionality | DENDRITIC NANOTECHNOLOGIES INC (US) | 2007-04-11 | — | — | CN | claimed |
| EP-1737899-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2006065266-A9 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2006-12-21 | — | — | WO | claimed |
| WO-2006115547-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-11-02 | — | — | WO | claimed |
| WO-2006065266-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-06-22 | — | — | WO | claimed |
| US-5266306-A | Cetylpyridinium chloride and n-acyl basic amino acid alkyl ester; bactericide, anticaries, antiplaque agents | SUNSTAR KABUSHIKI KAISHA (JP) | 1993-11-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | MYD88, TLR3, TMEM97 | LMNA 1465/4885KMT2A 2627/4885KDM4E 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.